Characteristics and outcomes in patients with acute myocardial infarction with ST-segment depression on initial electrocardiogram

American Heart Journal

Volumn 139, Issue 2, 2000, Pages 311-319

  Mahon, Niall G ^a   Codd, Mary B ^a   McKenna, Charles J ^a   O’rorke, Cliona ^a   McCann, Hugh A ^a   Sugrue, Declan D ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; T WAVE; TREATMENT OUTCOME;

AGED; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0033961382     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90241-2     Document Type: Article

References (42)

1. Schechtman KB, Capone R J, Kleiger RE, el al. Risk stratification of patients with non-Q-wave myocardial infarction: the critical role of ST-segment depression: the Diltiazem Reinfarction Study Research Group. Circulation 1989;80:1148-58.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.
3. Gruppo Italiano per Io Studio della Streptochinasi nell'lnForta Miocardica (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.
4. Metcalfe M J, Rawles JM, Shirreffs C, et al. Six-year follow-up of a consecutive series of patients presenting to the coronary care unit with acute chest pain: prognostic importance of the electrocardiogram. Br HeartJ 1990;63:267-72.
5. Odemuyiwa O, Peart I, AIbers C, et at. Reciprocal ST depression in acute myocardial infarction. Br Heart J 1985;54:479-83.
6. Tamuro A, Mikuriya Y, Kataoka H, et al. Emergent coronary anglographic findings of patients with ST depression in the inferior or lateral leads, or both, during anterior wall acute myocardial infarction. Am J Cardiol 1995;76:516-7.
7. Norell MS, Lyons JP, Gardener JE, et al. Significance of "reciprocal" ST segment depression: left ventriculographic observations during left anterior descending coronary angioplasty. J Am Coll Cardiol 1989; 13:1270-4.
8. Mahon NG, O'Rorke C, Codd MB, et al. Hospital mortality of acute myocardial infarction in the thrombolylic era. Heart 1999;81:478-82.
9. Prineas RJ, Crow RS, Blackburn H, The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. Littleton, Mass: John Wright; 1982.
10. SAS User's Guide (6.08). Cary, NC: SAS Institute Inc; 1989.
11. Brown N, Young T, Gray D, et al. Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart a, ack register. BMJ 1896;315:159-64.
12. Greenbaum RA, Morris R, Sritara P, et al. Reduced in-hospital mortality from acute myocardial infarction with general adoption of thrombolytic treatment in the North West Thames health region 1979-1991. Br Heart J 1995;74:493-6.
13. Maynard C, Weaver WD, Litwin PE, et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). Am J Cardiol 1993;72:877-82.
14. Clarke KW, Gray D, Keating NA, et al. Do women with acute myocardial infarction receive the same treatment as men? [see comments]. BMJ 1994;309:563-6.
15. Lee HS, Cross SJ, Rawles JM, et al. Patients with suspected myocardial infarction who present with ST depression. Lancet 1993;342:1204-7.
16. Varat MA. Non-transmural infarction: clinical distinction behveen palients with ST depression and those with T wave inversion. J Electrocardiol 1985; 18:15-20.
17. Lawn B, Vasaux C, Hood WB Jr, et al. Unresolved problems in coronary care. Am J Cardiol 1967;20:494-508.
18. Abbott JA, Scheinman MM. Nondiagnostic electrocardiogram in patients with acute myocardial infarction: clinical and anatomic correlations. Am J Med 1973;55:608-13.
19. Raunio H, Rissanen V, Romppanen T, et al. Changes in the QRS complex and ST segment in transmural and subendocardial myocardial infarctions: a clinicopathologic study. Am Heart J 1979;98:176-84.
20. Willich SN, Stone PH, Muller JE, et aL High-risk subgroups of patients with non-Q-wave myocardial infarction based on direction and severity of ST-segment deviation. Am Heart J 1987; 114:1110-9.
21. Pruitt RD, Dennis EW, Kinard SA. The difficult electrocardiographic diagnosis of myocardial infarction. Prog Cardiovasc Dis 1963;6:85.
22. Sugiura M, Okada R, Iizuka H. A clinicopathological study on the subendocardial infarction in the aged. Jpn Heart J 1969; 10:203-17.
23. Barbash GI, Reiner J, White HD, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights: Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995;26:1222-9.
24. Adams J, Trent R, Rawles J. Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment: the GREAT Group. BMJ 1993;307:409-13.
25. Antman EM, Tanasijevic M J, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
26. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia: GUSTO IIA Investigators. N Engl J Med 1996;335:1333-41.
27. Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing For cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
28. Fibrinalytic Therapy Trialists' (F1-I") Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-22.
29. Langer A, Goodman SG, Topoi EJ, et al. Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators) [see comments]. J Am Coll Cardiol 1996;27:1327-32.
30. Braunwald E, Cannon CP. Non-Q wave and ST segment depression myocardial infarction: is there a role for thrombolytic therapy? J Am Coll Cardiol 1996;27:1333-4.
31. Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998; 338:1498-505.
32. Anonymous: Inhibition of the platelet glycoprotein lib/Ilia receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med 1998;338:1488-97.
33. PURSUIT Trial Investigators (Platelet glycoprotein lib/Ilia in Unstable'angina: Receptor Suppression Using Integrifin Therapy). Inhibition of platelet glycoprotein lib/Ilia with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 339:436-43.
34. PARAGON Investigators (Platelet lib/Ilia Antagonism for the Reduction of Acute coronary syndrome events in a Global Organization Network). International, randomized, controlled trial of lamifiban (a platelet glycoprotein lib/Ilia inhibitor), heparin, or both in unstable angina. Circulation 1998;97:2386-2395.
35. Organisation to Assess Strategies for Ischaemic Syndromes (OASIS-2) Investigators. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Lancet 1999; 353:429-38.
36. Wallentin L. New antithrombotic treatment in unstable coronary syndrome: for whom? Lancet 1999;353,423.-4.
37. Cohen M, Denzers C, Gurfinkel EP, et al. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997;339:447-52.
38. Antman EM, Gioghann RP, McCabe CH, et al. Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of the TIM I 14 trial. J Am Coll Cardiol 1998;31 : 191A.
39. Gold HK, Caller BS, Yasuda T, et al. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant, tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/llla antibody in a canine preparation. Circulation 1998;97:670-7.
40. Erikssen J. ECG in strictly posterior myocardial infarction. Acto Med Scand 1970;187:465-9.
41. Wolff L, Mathur KS, Richman JL. The diagnosis of posterior myocardial infarction. Am Heart J 1953;46:21-36.
42. Sclarovsky S, Topaz O, Rechavia E, et al. Ischemic ST segment depression in leads V2-V3 as the presenting electrocardiographic feature of posterolateral wall myocardial infarction. Am Heart J 1987;113:1085-90.